Image not available in RecallScope.
Hemosil readiplastin (20 ml size)
Official notice
13 May 2022
An official Health Canada notice concerns Hemosil readiplastin (20 ml size). We recently received customer reports of performance issues with some vials of hemosil readiplastin PN 0020301400 Lot No, N0705526, including increased imprecision, out of range quality controls and prolonged sample results. Recall start date: Oct. 13, 2021 Published 2022-05-13.
What to do now
Contact the manufacturer if you require additional information.
Recall number
57428
Official notice
2022-05-13
The hazard
The hazard
We recently received customer reports of performance issues with some vials of hemosil readiplastin PN 0020301400 Lot No, N0705526, including increased imprecision, out of range quality controls and prolonged sample results. Recall start date: Oct. 13, 2021
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Recall Numbers
Lots
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Instrumentation Laboratory, Hemosil Readiplastin.
Source & status
Source & status
Recall details
Recall details
Recall number
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.